Brazilian single-dose dengue vaccine could help turn tide in the fight against fever

 "With just one injection, it provides good protection in a very elastic age range, from two to 60 incomplete years, according to the published results. It also has the differential of being able to be applied to those who have or have not already been infected by the dengue .

Protection was observed in all age groups, with 90% in adults aged 18 to 59, 77.8% in those aged seven to 17 and 80.1% in children aged two to six. The analysis of the effectiveness of the immunogen was carried out over two years with just under 17,000 volunteers in 16 research centers. The study is in its final phase and will complete in June 2024.

The next step will be to finalize the dossier with all the study information to apply for registration at Brazil's National Health Surveillance Agency (Anvisa) by the second half of 2024."


For more details:

Brazilian single-dose dengue vaccine could help turn tide in the fight against fever

And a related book:

https://amzn.to/3PnJ6ej



Comments

Popular posts from this blog

Research finds dramatic increase in cranial traumas as the first cities were being built, suggesting a rise in violence

Hook, Line, and Sinker: Mt. Ebal Curse Tablet Debunked?